Related Experiment Video
Updated: Jan 20, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy
Sarah R Clippinger1, Paige E Cloonan1, Lina Greenberg1
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110.
Insights
Familial dilated cardiomyopathy (DCM) is linked to sarcomeric protein mutations. This study reveals how a specific troponin-T mutation (ΔK210) impairs cardiomyocyte function and adaptation, offering insights into DCM development.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Cellular Mechanics
Background:
- Familial dilated cardiomyopathy (DCM) is a primary cause of sudden cardiac death and heart transplantation.
- Mutations in sarcomeric proteins are frequent causes of DCM, but the link between molecular changes and cellular dysfunction remains unclear.
Purpose of the Study:
- To investigate the molecular and cellular consequences of a specific DCM-associated mutation in troponin-T (ΔK210).
- To elucidate how this mutation affects cardiomyocyte organization, contractility, and mechanosensing.
Main Methods:
- Determined the molecular mechanism of the ΔK210 mutation.
- Employed computational modeling to predict the mutation's effect on sarcomere force.
- Assessed contractility, cellular hypertrophy, and adaptive responses to substrate stiffness in mutant cardiomyocytes.
Main Results:
- The ΔK210 mutation was found to reduce cardiomyocyte contractility.
- Mutant cardiomyocytes exhibited cellular hypertrophy and impaired adaptation to altered substrate stiffness.
- Computational modeling predicted a reduction in force per sarcomere due to the mutation.
Conclusions:
- The study links molecular mutations to cellular phenotypes in DCM.
- Alterations in mechanosensing are implicated as a key factor in DCM pathogenesis.
- Findings provide a deeper understanding of how sarcomeric protein mutations lead to cardiac dysfunction.
Abstract:
Familial dilated cardiomyopathy (DCM) is a leading cause of sudden cardiac death and a major indicator for heart transplant. The disease is frequently caused by mutations of sarcomeric proteins; however, it is not well understood how these molecular mutations lead to alterations in cellular organization and contractility. To address this critical gap in our knowledge, we studied the molecular and cellular consequences of a DCM mutation in troponin-T, ΔK210. We determined the molecular mechanism of ΔK210 and used computational modeling to predict that the mutation should reduce the force per sarcomere. In mutant cardiomyocytes, we found that ΔK210 not only reduces contractility but also causes cellular hypertrophy and impairs cardiomyocytes' ability to adapt to changes in substrate stiffness (e.g., heart tissue fibrosis that occurs with aging and disease). These results help link the molecular and cellular phenotypes and implicate alterations in mechanosensing as an important factor in the development of DCM.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Protein Families
Protein Families
Gene Families
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...
Gene Families
Cardiomyopathy IV: Restrictive Cardiomyopathy

